January / February 2020
Features
The latest in AI for managing DR
In ongoing investigations, artificial intelligence platforms have shown strong sensitivity and specificity in monitoring diabetic retinopathy.
Pipeline Report: Despite major approvals, the queue gets longer
Treatments for exudative disease were notable for four significant exits from our listing and seven new entries this year.
Pipeline Report: The path to GA treatment: What’s hot, what’s not
A review of past trials that disappointed and current trials that are showing promise as potential treatments.
How SD-OCT is enhancing our management of DR
The high speed of spectral-domain optical coherence tomography enables imaging of the retinal layers and vasculature all at once.
Departments
Editor's Page
Imaging Forum
Multimodal imaging and diagnosing ARN
Retinal whitening plus vitreous inflammation mean raised suspicion for acute retinal necrosis.
News
Social Media Specialist
Downsides of doctors on social media
How retina specialists can avoid the risks and pitfalls of putting their professional reputation out there.
Uveitis Forum
When to consider systemic treatments
Scenarios for systemic immunosuppression, and where conventional immunosuppressants and biologics fit in.
Current Issue
Continuing Medical Education
Additional Publications
Earlier Treatment Can Matter for Macular Edema Following Retinal Vein Occlusion
Sponsored by Regeneron
In pivotal trials, Eylea demonstrated its efficacy as a powerful treatment option for macular edema following RVO.
In pivotal trials, Eylea demonstrated its efficacy as a powerful treatment option for macular edema following RVO.
Treating Chronic Inflammation Associated With Uveitis Affecting the Posterior Segment in a Retina Setting with YUTIQ
GA: Recognizing the Burden
Treatment of Proliferative Diabetic Retinopathy
Improving Wet AMD Outcomes With a Fellow Eye Strategy
Eyepoint Yutiq: A Discussion Among Experts on the Treatment of Uveitis Affecting the Posterior Segment
